CN105498073A - Degradable implantation catheter carrying drug particles - Google Patents

Degradable implantation catheter carrying drug particles Download PDF

Info

Publication number
CN105498073A
CN105498073A CN201510931618.4A CN201510931618A CN105498073A CN 105498073 A CN105498073 A CN 105498073A CN 201510931618 A CN201510931618 A CN 201510931618A CN 105498073 A CN105498073 A CN 105498073A
Authority
CN
China
Prior art keywords
catheter body
catheter
drug particle
degradable implantation
carrying drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510931618.4A
Other languages
Chinese (zh)
Inventor
黄学全
何闯
杨丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
First Affiliated Hospital of TMMU
Original Assignee
First Affiliated Hospital of TMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by First Affiliated Hospital of TMMU filed Critical First Affiliated Hospital of TMMU
Priority to CN201510931618.4A priority Critical patent/CN105498073A/en
Publication of CN105498073A publication Critical patent/CN105498073A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/0007Special media to be introduced, removed or treated introduced into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/04General characteristics of the apparatus implanted

Abstract

The invention discloses a degradable implantation catheter carrying specific drug particles such as an iodine-125 brachytherapy source and sustained release drug particles such as sustained release fluorouracil particles and the like. The catheter comprises a catheter body for accommodating the drug particles and spacer blocks arranged in the catheter body and used for spacing drugs. The degradable implantation catheter carrying the drug particles can be loaded with sufficient antitumor drugs and carry the drugs to be implanted into a tumor part of a patient together, the antitumor drug particles realize predetermined distribution in the tumor, do not enter a blood vessel to be moved through flushing and can still keep predetermined distribution in fluid-containing and necrotic lacunas of a tumor body, and the implanted drug particles can follow a tumor change part correspondingly instead of being left outside a treated part when the catheter is degraded and the tumor body shrinks.

Description

Carry the degradable implantation catheter of drug particle
Technical field
The present invention relates to medical field, particularly relate to a kind of degradable implantation catheter carrying drug particle.
Background technology
It is low that the local dose that can overcome conventional entity oncotherapy mode systemic administration is preferably placed in antitumor drug local, weak effect, the defect that general toxicity is large, dense or the dosage of the medicine of tumor by local can not only be improved, and significantly can reduce general toxic reaction, and medicine is directly positioned over tumor tissues place and distribution meets and plans not only operating difficulties, need to carry out frequently implant procedure, length consuming time, increase wound and Operative risk.
Therefore, need a kind of degradable implantation catheter carrying drug particle, for holding antitumor drug, and then carry the tumor locus of antitumor drug together patients with implantation, in the degradable implantation catheter carrying drug particle, load enough antitumor drug and realize the reasonable layout of drug particle, to reach best therapeutic effect.Degradability contributes to realizing drug particles and can follow tumor with tumor regression and assemble gradually, is unlikely to enter in surrounding tissue.
Summary of the invention
In view of this, the object of this invention is to provide a kind of degradable implantation catheter carrying drug particle, enough antitumor drug can be loaded and carry the tumor cell place of medicine together patients with implantation, realizing long-term treatment by the slow releasing of antitumor drug, save medical expense.
The degradable implantation catheter carrying drug particle of the present invention, comprise catheter body for holding medicine and be located in catheter body for by spacer block spaced apart for medicine.
Further, described catheter body and spacer block are made by degradation material.
Further, the internal diameter of described catheter body is 0.9-1.0mm, and wall thickness is 0.08 ~ 0.12mm.
Further, described catheter body sidewall arranges at least one side opening or catheter body sidewall opening is formed C type tubular construction.
Further, described side opening along catheter body length to spacing be 10 ~ 20mm.
Further, one end of described catheter body is closed, and the other end is bell mouth shape, and its blind end is tack, tip, round end and can be forked.
Further, described degradation material is biological erosion to separate or biodegradable metal, alloy or polymer.
Further, described degradation material be magnesium, ferrum, magnesium base alloy, polylactic acid, polyglycolic acid, polylactic-co-glycolic acid, polyamide, polyester, polyesteramide, polyanhydride, poe, polyphosphazene, false polyamino acid, polyglycereol-sebacate, polycaprolactone, polycaprolactone derivatives, based on amino alcohol polyesteramide, poly-octane glycol citrate, hydrogel or curable biology can resorbent elastomers.
The invention has the beneficial effects as follows: the degradable implantation catheter carrying drug particle of the present invention, enough antitumor drug can be loaded and carried the tumor cell place of medicine together patients with implantation by this degradable implantation catheter carrying drug particle, realize long-term treatment by the slow releasing of antitumor drug, save medical expense.
Accompanying drawing explanation
Fig. 1 is structural representation of the present invention.
Detailed description of the invention
Fig. 1 is structural representation of the present invention; As shown in the figure: the degradable implantation catheter carrying drug particle of the present embodiment, comprise the catheter body 2 for holding medicine 1 and be located in catheter body 2 for by spacer block 3 spaced apart for medicine 1; Catheter body 2 is for having the flexible tubular structure of certain degree of hardness, and medicine 1 can be discharged by the mouth of pipe of catheter body 2 end, also can on catheter body 2 sidewall machining hole, medicine 1 is discharged by hole, all can realize object of the present invention; Rationally can arrange length and the interval of spacer block 3 according to disease sites, and then medicine 1 can be made corresponding with disease sites after catheter body 2 implant into body, energy is drug administration 1 dosage reasonably, and ensure therapeutic effect.
In the present embodiment, described catheter body 2 and spacer block 3 are made by degradation material; Catheter body 2 and spacer block 3 can be absorbed by the body after implanting gradually, simplify therapeutic process, reduce the infringement to human body.
In the present embodiment, the internal diameter of described catheter body 2 is 0.9 ~ 1.0mm, and wall thickness is 0.08 ~ 0.12mm; Caliber is little, and wall thickness is thin, is suitable for, through puncture needle implant surgery, being beneficial to degraded and absorbed; Can be used for holding the cylindrical drug particles that diameter is about 0.8mm, and discharge through puncture needle, guarantee to reach medicine ideal distribution state.
In the present embodiment, described catheter body 2 sidewall arranges at least one side opening 4 or catheter body 2 sidewall opening is formed C type tubular construction, namely on the sidewall of catheter body 2, open a partial sidewall arriving several side opening 4 or ablation catheter body 2 form C type tubular construction, size and the density of side opening 4 are rationally set according to medicine 1 absorbability, or the width of C type pipe lateral opening is rationally set according to medicine 1 absorbability, one of them side opening 4 is located at catheter body 2 bottom, when medicine 1 is loaded deaeration be convenient to filling medicine and medicine discharge gradually, act on disease sites, described side opening 4 is bellmouth orifice structure, namely the aperture of side opening 4 becomes large from inside to outside gradually along catheter body 2 radial direction, medicine 1 release duration can be controlled preferably, increase active area simultaneously, improve therapeutic effect, in catheter body 2, corresponding other side openings 4 except least significant end are provided with the diaphragm being sealed in this part side opening 4 outer end, described diaphragm is one-body molded with catheter body 2 and diaphragm is equal with the outer surface of catheter body 2, diaphragm is by can biological erosion separate or biodegradable metal, alloy or polymer are made, side opening 4 can be sealed by diaphragm, avoid implanting prodrug 1 to trickle down, therefore medicine 1 can be powder or liquid, arrange diaphragm makes the outer surface of catheter body 2 become level and smooth simultaneously, be convenient to implant, implant rear film to be preferentially degraded, side opening 4 is opened, realize the release of medicine 1.
In the present embodiment, described side opening 4 along catheter body 2 long to spacing be 10 ~ 20mm; Make medicine 1 can directly act on sufferer position, improve therapeutic effect, reduce dosage, reduce the side effect of medication.
In the present embodiment, one end of described catheter body 2 is closed, and the other end is bell mouth shape, and its blind end is tack, tip, round end and can be forked; Conveniently load in catheter body 2 by medicine 1, blind end is set to forked can increase medicine 1 active area, utilizes bifurcation structure effectively to locate catheter body 2 simultaneously, avoids catheter body 2 to be shifted, and ensures therapeutic effect.
In the present embodiment, described degradation material is biological erosion to separate or biodegradable metal, alloy or polymer; Catheter body 2 can be absorbed by the body after implanting gradually, simplifies therapeutic process, reduces the infringement to human body.
In the present embodiment, described degradation material is magnesium, ferrum, magnesium base alloy, polylactic acid, polyglycolic acid, polylactic-co-glycolic acid, polyamide, polyester, polyesteramide, polyanhydride, poe, polyphosphazene, false polyamino acid, polyglycereol-sebacate, polycaprolactone, polycaprolactone derivatives, based on the polyesteramide of amino alcohol, poly-octane glycol citrate, hydrogel or curable biology can resorbent elastomers, the polymer of Based PC needs extra cross-linking agent such as lysinediisocyanate or 2, two (6-caprolactone-4-base) propane of 2-is to obtain elastomer properties, also the copolymer of above material can be used, mixture and combination, the compositions in weight percentage of described hydrogel comprises corn starch 4.5-4.7, acrylic acid 21.4-22.5, acrylamide 9-9.5, Ammonium persulfate. 3.2-4.5, calcium carbonate 4.5-4.7, sodium hydroxide 9.5-9.9, water surplus, namely except corn starch, acrylic acid, acrylamide, Ammonium persulfate., calcium carbonate, beyond sodium hydroxide, all the other are water, when preparing hydrogel, first that sodium hydroxide is soluble in water, and add acrylic acid and carry out pretreatment, add corn starch, acrylamide and calcium carbonate successively again, after stirring reaction of heating, add initiator and carry out graft polymerization reaction, then reacted liquid is poured in mould, freeze-day with constant temperature, have technique simple, product is nontoxic, biodegradation rate is fast and apply the advantages such as wide.
What finally illustrate is, above embodiment is only in order to illustrate technical scheme of the present invention and unrestricted, although with reference to preferred embodiment to invention has been detailed description, those of ordinary skill in the art is to be understood that, can modify to technical scheme of the present invention or equivalent replacement, and not departing from aim and the scope of technical solution of the present invention, it all should be encompassed in the middle of right of the present invention.

Claims (8)

1. carry a degradable implantation catheter for drug particle, it is characterized in that: comprise catheter body for holding medicine and be located in catheter body for by spacer block spaced apart for medicine.
2. the degradable implantation catheter carrying drug particle according to claim 1, is characterized in that: described catheter body and spacer block are made by degradation material.
3. the degradable implantation catheter carrying drug particle according to claim 2, is characterized in that: the internal diameter of described catheter body is 0.9 ~ 1.0mm, and wall thickness is 0.08 ~ 0.12mm.
4. the degradable implantation catheter carrying drug particle according to claim 2, is characterized in that: described catheter body sidewall arranges at least one side opening or catheter body sidewall opening is formed C type tubular construction.
5. the degradable implantation catheter carrying drug particle according to claim 4, is characterized in that: described side opening along catheter body length to spacing be 10 ~ 20mm.
6. the degradable implantation catheter carrying drug particle according to claim 2, is characterized in that: one end of described catheter body is closed, and the other end is bell mouth shape, and its blind end is tack, tip, round end and can be forked.
7. the degradable implantation catheter carrying drug particle according to claim 2, is characterized in that: described degradation material for separating or biodegradable metal, alloy or polymer in biological erosion.
8. the degradable implantation catheter carrying drug particle according to claim 2, is characterized in that: described degradation material be magnesium, ferrum, magnesium base alloy, polylactic acid, polyglycolic acid, polylactic-co-glycolic acid, polyamide, polyester, polyesteramide, polyanhydride, poe, polyphosphazene, false polyamino acid, polyglycereol-sebacate, polycaprolactone, polycaprolactone derivatives, based on amino alcohol polyesteramide, poly-octane glycol citrate, hydrogel or curable biology can resorbent elastomers.
CN201510931618.4A 2015-12-14 2015-12-14 Degradable implantation catheter carrying drug particles Pending CN105498073A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510931618.4A CN105498073A (en) 2015-12-14 2015-12-14 Degradable implantation catheter carrying drug particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510931618.4A CN105498073A (en) 2015-12-14 2015-12-14 Degradable implantation catheter carrying drug particles

Publications (1)

Publication Number Publication Date
CN105498073A true CN105498073A (en) 2016-04-20

Family

ID=55706614

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510931618.4A Pending CN105498073A (en) 2015-12-14 2015-12-14 Degradable implantation catheter carrying drug particles

Country Status (1)

Country Link
CN (1) CN105498073A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107456665A (en) * 2017-09-13 2017-12-12 成都迪康中科生物医学材料有限公司 A kind of degradable conduit for loading drug particle
CN107970522A (en) * 2017-11-24 2018-05-01 黑龙江工程学院 A kind of degradable metal base subcutaneously carries embedding thing of medicine and preparation method thereof
CN108098735A (en) * 2017-12-12 2018-06-01 上海大学 A kind of biological micro-nano robot and its construction method based on biological 3D printing

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2701461Y (en) * 2003-12-26 2005-05-25 冯梅 Lumen internal metal network bracket for local radiotherapy and chemical therapy particle
CN2905096Y (en) * 2006-01-01 2007-05-30 张德祥 Catheter for implanting I125 source into canals
CN101069660A (en) * 2007-06-20 2007-11-14 中国人民解放军第三军医大学第一附属医院 Biliary-tract carriage carrying about medicine and preparing method therefor
CN102470237A (en) * 2009-06-26 2012-05-23 塔里斯生物医药公司 Solid drug tablets for implantable drug delivery devices
CN103300950A (en) * 2012-03-07 2013-09-18 常州乐奥医疗科技有限公司 Pipeline support capable of carrying drug particles
CN203710540U (en) * 2013-12-11 2014-07-16 天津赛德医药研究院有限公司 Connecting chain capable of degrading radioactive sealing seed sources

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2701461Y (en) * 2003-12-26 2005-05-25 冯梅 Lumen internal metal network bracket for local radiotherapy and chemical therapy particle
CN2905096Y (en) * 2006-01-01 2007-05-30 张德祥 Catheter for implanting I125 source into canals
CN101069660A (en) * 2007-06-20 2007-11-14 中国人民解放军第三军医大学第一附属医院 Biliary-tract carriage carrying about medicine and preparing method therefor
CN102470237A (en) * 2009-06-26 2012-05-23 塔里斯生物医药公司 Solid drug tablets for implantable drug delivery devices
CN103300950A (en) * 2012-03-07 2013-09-18 常州乐奥医疗科技有限公司 Pipeline support capable of carrying drug particles
CN203710540U (en) * 2013-12-11 2014-07-16 天津赛德医药研究院有限公司 Connecting chain capable of degrading radioactive sealing seed sources

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107456665A (en) * 2017-09-13 2017-12-12 成都迪康中科生物医学材料有限公司 A kind of degradable conduit for loading drug particle
CN107456665B (en) * 2017-09-13 2018-06-29 成都迪康中科生物医学材料有限公司 A kind of degradable conduit for loading drug particle
CN107970522A (en) * 2017-11-24 2018-05-01 黑龙江工程学院 A kind of degradable metal base subcutaneously carries embedding thing of medicine and preparation method thereof
CN108098735A (en) * 2017-12-12 2018-06-01 上海大学 A kind of biological micro-nano robot and its construction method based on biological 3D printing
CN108098735B (en) * 2017-12-12 2021-11-05 上海大学 Biological micro-nano robot based on biological 3D printing and construction method thereof

Similar Documents

Publication Publication Date Title
US8197461B1 (en) Controlled release system for delivering therapeutic agents into the inner ear
KR100483447B1 (en) Device for local administration of solid and semisolid formulations, sustained-release formulations for parenteral administration and method of preparation
US20180339143A1 (en) Implantable device for intraperitoneal drug delivery
US5629008A (en) Method and device for long-term delivery of drugs
US8999945B2 (en) Methods, compositions and systems for local delivery of drugs
KR101538748B1 (en) Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens
JP5296383B2 (en) Indwelling treatment device for treatment of ablation cavity wall
US20020111603A1 (en) Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
CN106039547A (en) Expandable devices and methods therefor
PT93170B (en) METHOD FOR PREPARING DISTRIBUTING DEVICES IN CAPSULES CONTAINING AN ACTIVE INGREDIENT
JP2010526635A (en) Delivery device for delivering biologically active agents to internal tissues of the body
CA2441114A1 (en) Controlled resorption of medical implants
CN105498073A (en) Degradable implantation catheter carrying drug particles
JP2003250909A (en) Method and device for delivering chemical for long period of time
CN105324137A (en) Trans-arterial drug delivery
WO2012047931A1 (en) Device for local drug delivery and treatment of cerebral edema and other brain-related diseases
CN107106823A (en) Resist blocking and that uterine cavity sacculus
CN101959542A (en) Drug delivery system
CN205515980U (en) Pipe is implanted to medicine
WO2016074561A1 (en) Microtubule provided with radionuclide, and manufacturing method and application therefor
CN207785644U (en) GI Medicine esophagus medicator
CN211410672U (en) Balloon carrying radioactive particles
KR102221074B1 (en) A stent comprising biodegradable polymer and nitinol and method for preparing thereof
CN202387022U (en) Controllable biodegradable drug slow-release membrane layer support
CN211410654U (en) Gastroenterology esophagus medicine coating device

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160420